Atlas FDA

PD-L1 IHC NIVOLUMAB PHARMDX

FDA premarket approval P150025/S004 · decided 2017-03-24

Approval details

PMA number
P150025
Supplement
S004
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
PD-L1 IHC NIVOLUMAB PHARMDX
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Applicant
Agilent Technologies, Inc.
Date received
2016-12-27
Decision date
2017-03-24
Days to decision
87 days
Decision code
APPR
Product code
PLS
Advisory committee
Pathology
Expedited review
No
Location
Santa Clara, CA
Statement
Approval for an update to DakoLink software version 4.2.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GenetiSure Dx Postnatal Assay (K163367)Agilent Technologies, Inc.2017-08-11
MODIFICATION TO DEVICE LINK SYSTEM, MODEL M2376A (K012094)Agilent Technologies, Inc.2001-07-20
AGILENT M2636B TELEMON B MONITOR (TELEMON B) (K011824)Agilent Technologies, Inc.2001-07-02
HEARTSTREAM XL DEFIBIBRILLATOR/MONITOR, MODEL M4735A, HEARTSTREAM XLT DEFIBRILLATOR/MONITOR.MODEL M2500B (K010634)Agilent Technologies, Inc.2001-06-11
M2376A DEVICELINK SYSTEM, MODEL M2376A (K011578)Agilent Technologies, Inc.2001-06-08
HEARTSTREAM ATTENUATED DEFIBRILLATION PADS, MODEL M3870A (K003819)Agilent Technologies, Inc.2001-05-02
AGILENT INFORMATION CENTER SOFTWARE FOR M3150,M3151,M3153 AND M3154 (K011093)Agilent Technologies, Inc.2001-05-01
M2376A DEVICELINK SYSTEM (K010453)Agilent Technologies, Inc.2001-03-02